Mepolizumab for Treatment of Severe Eosinophilic Asthma: A 5-Year Real-World Experience
J. investig. allergol. clin. immunol
; 33(3): 209-210, 2023.
Article
in English
| IBECS
| ID: ibc-221941
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Pulmonary Eosinophilia
/
Asthma
/
Anti-Asthmatic Agents
/
Antibodies, Monoclonal, Humanized
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
English
Journal:
J. investig. allergol. clin. immunol
Year:
2023
Document type:
Article
Institution/Affiliation country:
August Pi i Sunyer Biomedical Research Institute (IDIBAPS)/Spain
/
Hospital Clínic Barcelona/Spain
/
Hospital Santa Creu i Sant Pau/Spain